Please ensure Javascript is enabled for purposes of website accessibility

China Green May Have a Problem

By Neha Chamaria – Updated Apr 6, 2017 at 6:56PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

China Green reported solid numbers, but all might not be as good as it seems.

This Chinese play has rocked the Street with some solid numbers. China Green Agriculture's (NYSE: CGA) fourth-quarter bottom line has surged 57.4%, driven by higher sales.

But sadly, all might not be well at China Green.

The numbers
China Green's revenues have been shooting through the roof. Buoyed by a significant contribution from Gufeng, which China Green acquired last year, its revenues surged more than three times to $60.3 million from $16.2 million a year ago. Gufeng contributed a huge 67% to the total sales. China Green's other subsidiaries also reported higher sales.

However, what's worth noting here is that on one hand, Gufeng contributed to top line, but on the other it also resulted in astonishingly high costs. China Green's cost of sales went up by a whopping 452.6% (yes, that is the correct figure) to $39.2 million, 80% of which was related to Gufeng.

What's concerning is that this surge in cost of sales is way above the 272% rise in revenues, which isn't good news for any company. Obviously, China Green's gross profit margin has slipped drastically, from 56.3% to 35% year over year.

However, in spite of such unbelievably high costs, strong top-line growth helped China Green's bottom line jump 57.4% to $9.4 million.

The Gufeng growth
The acquisition of Beijing-based chemical company Gufeng is adding to production capacity as well as helping China Green expand operations. For instance, in the last quarter, Gufeng started delivering compound fertilizers to the emerging market of India. Earlier this year, Gufeng also signed its largest export contract with a China-based company. Looks like the Gufeng buy was a good one.

China Green has also been spending on new products, introducing nine new ones in its last quarter. Moreover, it has plans to develop more humic acid-based fertilizer products. This will definitely add value to the company's business and, more importantly, place it in a better position to take on major competitor Yongye International (Nasdaq: YONG).  

On a high
The chemicals and fertilizer industry has been on a high, with things going just too well for it. Most of the players have reported hot numbers driven by the agriculture boom. PotashCorp (NYSE: POT), for instance, reported a staggering 75% surge in its second-quarter bottom line, driven by higher sales and prices. Similarly, higher sales also drove up Mosaic's fourth-quarter bottom line by 64%.

And the agricultural sector is not showing any signs of slowing down. China Green also stands to gain from it all. But let's not forget that it will also mean intensifying competition, as some U.S. chemical players have been eyeing markets such as China more keenly now.

Monsanto (NYSE: MON), for instance, is in talks with China-based Sinochem for strengthening ties, eyeing a deeper penetration in China. Diversified chemical player Dow Chemical (NYSE: DOW) is also focusing on expanding sales networks in China. A KPMG report also states the company's intention of building a large manufacturing site in China. These moves indicate that steeper competition may be on its way in the Chinese chemical market.

The Foolish bottom line
The recent numbers might be exciting, but cost efficiencies remain a major concern for China Green. How long can a company truly benefit from rising sales if its costs rise by a much higher percentage at the same time? And the main cause of concern here is that these higher costs are associated with the production and selling of Gufeng's products. Clearly, the company has to control costs first if it wants to fully capitalize on Gufeng.

China Green may be a Motley Fool Global Gains recommendation, but I'm personally going to wait for better cost-control measures before getting too bullish about the company. And once they are in place, given the good performance, strong growth plans, and optimistic industry outlook, I might well have a better view of the stock.

In the meanwhile, stay up to speed on the top news and analysis on China Green, or any other stock, by clicking here to add it to your stock Watchlist.

Fool contributor Neha Chamaria does not own shares of any of the companies mentioned in this article. The Motley Fool owns shares of China Green Agriculture and Yongye International. Motley Fool newsletter services have recommended buying shares of Yongye International and China Green Agriculture, as well as creating a synthetic long position in Monsanto. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

China Green Agriculture, Inc. Stock Quote
China Green Agriculture, Inc.
CGA
$6.93 (-2.43%) $0.17
Nutrien Stock Quote
Nutrien
POT
DuPont de Nemours, Inc. Stock Quote
DuPont de Nemours, Inc.
DOW
Monsanto Company Stock Quote
Monsanto Company
MON
Yongye International, Inc. Stock Quote
Yongye International, Inc.
YONG.DL

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.